Thu, January 12, 2017

by: WOPRAI

XOMA Corporation (NASDAQ:XOMA), Down After BUYINS.NET Report Predicted Stock Would Go Down Due To Conditions Outlined In Our Re

by: WOPRAI

Endocyte Inc. (NASDAQ:ECYT), Down After BUYINS.NET Report Predicted Stock Would Go Down Due To Conditions Outlined In Our Repor

by: WOPRAI

Kite Pharma Inc. (NASDAQ:KITE), Down After BUYINS.NET Report Predicted Stock Would Go Down Due To Conditions Outlined In Our Re

by: WOPRAI

PED, NATI, ENV, GNE, SN, Expected to Trade Lower After Bearish Insider Trading

by: WOPRAI

CSM, SBNY, LLNW, SCHB, SODA, URTY Are Seasonally Ripe To Go Up In the Next Five Weeks

by: WOPRAI

HIMX, XRT, RYH, FXR, SCHX, EUFN Are Seasonally Ripe To Go Up In the Next Five Weeks

by: WOPRAI

TRNO, FNGN, WSR, AAT Are Seasonally Ripe To Go Up In the Next Five Weeks

by: WOPRAI

CLY, VR, GAZ, EXK, LOV, ISR Are Seasonally Ripe To Go Down In the Next Five Weeks

by: WOPRAI

TAC, CUTR Are Seasonally Ripe To Go Down In the Next Five Weeks

by: WOPRAI

CFNL, BBT Expected To Be Up Before Next Earnings Releases

by: WOPRAI

UNH Expected To Be Down Before Next Earnings Releases

by: WOPRAI

Brian Wieser Downgraded (ADBE) to Hold and Decreased Target to $104 on, Jan 12th, 2017

by: WOPRAI

Andrew Lim Upgraded (BAC) to Strong Buy and Increased Target to $32 on, Jan 12th, 2017

by: WOPRAI

Walter Spracklin Initiated (BA) at Sell and Held Target at $136 on, Jan 12th, 2017

by: WOPRAI

John Kim Downgraded (AIV) to Hold on, Jan 12th, 2017

by: WOPRAI

Matthew Breese Downgraded (CBU) to Strong Sell on, Jan 12th, 2017

by: WOPRAI

Mariya Kahn Initiated (AMX) at Strong Sell and Held Target at $10 on, Jan 12th, 2017

by: WOPRAI

Ken Herbert Initiated (TDG) at Buy and Held Target at $316 on, Jan 12th, 2017

by: WOPRAI

PT Luther Upgraded (CCJ) to Hold on, Jan 12th, 2017

by: WOPRAI

Curt Woodworth Downgraded (X) to Hold and Increased Target to $30 on, Jan 12th, 2017

by: WOPRAI

Meyer Shields Downgraded (THG) to Sell and Decreased Target to $81 on, Jan 12th, 2017

by: WOPRAI

Curt Woodworth Downgraded (STLD) to Hold and Increased Target to $36 on, Jan 12th, 2017

by: WOPRAI

Toshiya Hari Downgraded (SWKS) to Hold on, Jan 12th, 2017

by: WOPRAI

Darren Horowitz Upgraded (TRGP) to Buy and Held Target at $62 on, Jan 12th, 2017

Wed, January 11, 2017

by: WOPRAI

Vanda Pharmaceuticals Inc. (NASDAQ:VNDA), Down After BUYINS.NET Report Predicted Stock Would Go Down Due To Conditions Outlined

by: WOPRAI

EBR SqueezeTrigger Price is $6.62. There is $933,584 That Short Sellers Still Need To Cover.

by: WOPRAI

SYNNEX Corporation (NYSE:SNX), Up After BUYINS.NET Report Predicted Stock Would Go Up Due To Conditions Outlined In Our Report

by: WOPRAI

MV Oil Trust (NYSE:MVO), Up After BUYINS.NET Report Predicted Stock Would Go Up Due To Conditions Outlined In Our Report

by: WOPRAI

support.com Inc. (NASDAQ:SPRT), Down After BUYINS.NET Report Predicted Stock Would Go Down Due To Conditions Outlined In Our Re

by: WOPRAI

OSI Systems, Inc. (NASDAQ:OSIS), Down After BUYINS.NET Report Predicted Stock Would Go Down Due To Conditions Outlined In Our R

by: WOPRAI

AVEO Pharmaceuticals Inc. (NASDAQ:AVEO), Down After BUYINS.NET Report Predicted Stock Would Go Down Due To Conditions Outlined

by: WOPRAI

Omeros Corporation (NASDAQ:OMER), Down After BUYINS.NET Report Predicted Stock Would Go Down Due To Conditions Outlined In Our

by: WOPRAI

Prothena Corporation plc (NASDAQ:PRTA), Down After BUYINS.NET Report Predicted Stock Would Go Down Due To Conditions Outlined I

by: WOPRAI

Aduro Biotech Inc. (NASDAQ:ADRO), Down After BUYINS.NET Report Predicted Stock Would Go Down Due To Conditions Outlined In Our

by: WOPRAI

Alkermes PLC (NASDAQ:ALKS), Down After BUYINS.NET Report Predicted Stock Would Go Down Due To Conditions Outlined In Our Report

by: WOPRAI

bluebird bio Inc. (NASDAQ:BLUE), Down After BUYINS.NET Report Predicted Stock Would Go Down Due To Conditions Outlined In Our R

by: WOPRAI

VF Corporation (NYSE:VFC), Down After BUYINS.NET Report Predicted Stock Would Go Down Due To Conditions Outlined In Our Report

by: WOPRAI

Atara Biotherapeutics Inc. (NASDAQ:ATRA), Down After BUYINS.NET Report Predicted Stock Would Go Down Due To Conditions Outlined

by: WOPRAI

CIX SqueezeTrigger Price is $12.21. There is $307,400 That Short Sellers Still Need To Cover.

by: WOPRAI

ENTL SqueezeTrigger Price is $19.99. There is $13,763,472 That Short Sellers Still Need To Cover.

by: WOPRAI

Pure Cycle Corporation (NASDAQ:PCYO), Up By $0.37 (7.36%) After BUYINS.NET SqueezeTrigger Report Released on Tuesday, January 1

by: WOPRAI

Wireless Telecom Group, Inc. (NYSE:WTT), Up By $0.12 (6.98%) After BUYINS.NET SqueezeTrigger Report Released on Thursday, Janua

by: WOPRAI

ECA Marcellus Trust I (NYSE:ECT), Up After BUYINS.NET Report Predicted Stock Would Go Up Due To Conditions Outlined In Our Repo

by: WOPRAI

Park Sterling Corporation (NASDAQ:PSTB), Down After BUYINS.NET Report Predicted Stock Would Go Down Due To Conditions Outlined

by: WOPRAI

Town Sports International Holdings Inc. (NASDAQ:CLUB), Up After BUYINS.NET Report Predicted Stock Would Go Up Due To Conditions

by: WOPRAI

BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX), Down After BUYINS.NET Report Predicted Stock Would Go Down Due To Conditions Outl

by: WOPRAI

Akamai Technologies Inc. (NASDAQ:AKAM), Up After BUYINS.NET Report Predicted Stock Would Go Up Due To Conditions Outlined In Ou

by: WOPRAI

G Willi-Food International Ltd (NASDAQ:WILC), Up By $0.54 (8.84%) After BUYINS.NET SqueezeTrigger Report Released on Tuesday, J

John Kim Downgraded (AIV) to Hold on, Jan 12th, 2017

John Kim of BMO Capital, Downgraded "Apartment Investment and Management Company" (AIV) to Hold on, Jan 12th, 2017.

John has made no other calls on AIV in the last 4 months.



There are 2 other peers that have a rating on AIV. Out of the 2 peers that are also analyzing AIV, 1 agrees with John's Rating of Hold. Following is the relevant analyst calls for the last 4 months

  • Aaron Hecht of "JMP Securities" Downgraded from Buy to Hold on, Thursday, October 20th, 2016


This is the rating of the analyst that currently disagrees with John

  • Richard Anderson of "Mizuho" Upgraded from Hold to Strong Buy on, Monday, October 31st, 2016